Results 91 to 100 of about 19,509 (202)
, 1986 The antihypertensive efficacy and tolerability of bisoprolol and atenolol were compared in the Bisoprolol International Multicenter Study (BIMS). In 104 patients with essential hypertension (21 to 70 years of age and diastolic blood pressures (DBP) of ...
Brunner HR +9 more
core +1 more source
Substantiation of conditions for determination of related substances in bisoprolol fumarate by HPLC
Регуляторные исследования и экспертиза лекарственных средств, 2018 The article summarizes the results of information analysis of bisoprolol fumarate synthesis methods which differ in the number of stages and in raw materials used, and are associated with the major identified impurities A, E and G, according to the ...
O. A. Baturina +7 more
doaj
Bisoprolol in the treatment of chronic heart failure [PDF]
, 2012 Cardioselective beta-blocker bisoprolol has been successfully used for the treatment of patients with CHF. Bisoprolol therapy leads to a significant reduction in the risk of total, sudden death, death from heart disease.
Кремнева, Л. В. +5 more
core
Oral bisoprolol improves surgical field during functional endoscopic sinus surgery
, 2014 Background: The success of functional endoscopic sinus surgery (FESS) depends on visual clarity of the surgical field, through the endoscope. The objective of this double-blind, randomized, controlled study was to determine if a pre-operative dose of ...
Verghese T Cherian +2 more
core +1 more source
Терапевтический архив, 2004 Aim. To assess the effect of a long-term (6 months) treatment with selective beta-blocker bisoprolol, cytoprotector trimetazidine and their combination on the clinical course, left ventricular morphofunctional parameters and quality of life of patients ...
Т A Fedorova +4 more
doaj
Рациональная фармакотерапия в кардиологии, 2016 Aim. To compare efficacy of carvedilol and bisoprolol in patients with chronic heart failure (CHF) and diabetes mellitus (DM) type 2 after myocardial infarction (MI).Material and methods.
M. E. Statsenko +4 more
doaj +1 more source
Folia Medica Indonesiana, 2017 Heart failure (HF) is the final common stage of many diseases of the heart. NT-proBNP levels are increased in HF and correlate well with ventricular wall stress and severity of HF. Combination therapy with Bisoprolol and ACE-inhibitor decreases NT-proBNP
Reine Risa Risthanti +2 more
doaj +1 more source
Bisoprolol for congestive heart failure
, 2008 Background: beta-Blockers are a cornerstone in the treatment of systolic heart failure treatment, but not all beta-blockers are effective or in this setting. Objective: To define the role of bisoprolol, a highly selective beta(1)-antagonist in congestive
Rosenberg, J., Gustafsson, F.
core
Терапевтический архив, 2009 Aim. To study effects of a cardioselective beta-adrenoblocker bisoprolol on vascular wall endothelium and external respiration function in stable angina of effort combined with chronic obstructive pulmonary disease (COPD).
N Yu Grigor'eva +11 more
doaj
BMC Cardiovascular Disorders, 2019 Background Non-cardiac surgery for hypertrophic obstructive cardiomyopathy (HOCM) is considered to require meticulous perioperative care. β-blockers are considered the first-line drugs for patients with HOCM, and they play a key role in preventing ...
Yoichi Imori +8 more
doaj +1 more source